I-BRD9

Catalog No.S7835 Batch:S783501

Print

Technical Data

Formula

C22H22F3N3O3S2

Molecular Weight 497.55 CAS No. 1714146-59-4
Solubility (25°C)* In vitro DMSO 99 mg/mL (198.97 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description I-BRD9 (GSK602) is a potent and selective BRD9 inhibitor with pIC50 of 7.3, while this compound displayed a pIC50 of 5.3 against BRD4.
Targets
BRD9 [1]
(Cell-free assay)
BRD4 [1]
(Cell-free assay)
7.3(pIC50) 5.3(pIC50)
In vitro I-BRD9 is identified through structure-based design, leading to greater than 700-fold selectivity over the BET family and 200-fold over the highly homologous bromodomain-containing protein 7 (BRD7). This compound is used to identify genes regulated by BRD9 in Kasumi-1 cells involved in oncology and immune response pathways and to the best of our knowledge, represents the first selective tool compound available to elucidate the cellular phenotype of BRD9 bromodomain inhibition.

Protocol (from reference)

References

  • https://pubmed.ncbi.nlm.nih.gov/25856009/

Selleck's I-BRD9 Has Been Cited by 19 Publications

BET Inhibition Enhances TNF-Mediated Anti-Tumor Immunity [ Cancer Immunology Research, November 15, 2021, nan]
The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9 [ Cancer Research Communications, January 30, 2024, 237-252] PubMed: 38126767
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells [ International Journal of Molecular Sciences, January 11, 2024, 905] PubMed: 38255982
In-depth functional analysis of BRD9 in fetal hematopoiesis reveals context-dependent roles [ iScience, February 12, 2025, 112010] PubMed: 40109374
BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma [ Cell Rep Med, 2025, 6(8):102258] PubMed: 40744020
Prostate cancer exploits BRD9-driven metabolic reprogramming to shape the aggressive phenotype [ Cell Death Dis, 2025, 16(1):326] PubMed: 40263302
Prostate cancer exploits BRD9-driven metabolic reprogramming to shape the aggressive phenotype [ Cell Death & Disease, 2025, 326] PubMed: 40263302
In-depth functional analysis of BRD9 in fetal hematopoiesis reveals context-dependent roles [ iScience, 2025, 28(3):112010] PubMed: 40109374
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells [ International Journal of Molecular Sciences, 2024, 905] PubMed: 38255982
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells [ Int J Mol Sci, 2024, 25(2)905] PubMed: 38255982

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.